AGNG – Global X Aging Population ETF
Global X Aging Population ETF (AGNG) is a Health ETF, issued by Global X Funds, $83.6M in assets, 0.50% expense ratio.
Returns as of Oct 23, 2026: 1 week +3.3%, 1 year +19.7%.
Targets companies benefiting from aging population trend in developed markets, including biotechnology, healthcare, and senior living sectors.
Top holdings
- UCB – UCB SA, 4.4%
- JNJ – Johnson & Johnson, 3.4%
- RO – Roche Holding AG, 3.4%
- LLY – Eli Lilly and Company, 3.4%
- MRK – Merck & Company Inc, 3.3%
- AZN – AstraZeneca PLC ADR, 3.3%
- WELL – Welltower Inc, 3.2%
- REGN – Regeneron Pharmaceuticals Inc, 3.1%
- EW – Edwards Lifesciences Corp, 2.9%
- ABBV – AbbVie Inc, 2.9%
- MDT – Medtronic PLC, 2.8%
- AMGN – Amgen Inc, 2.8%
- 4519 – Chugai Pharmaceutical Co. Ltd., 2.8%
- SYK – Stryker Corporation, 2.5%
- BMY – Bristol-Myers Squibb Company, 2.4%
- BSX – Boston Scientific Corp, 2.4%
- SDZ – Sandoz Group AG, 2.4%
- VTR – Ventas Inc, 2.4%
- BGNE – BeiGene Ltd, 2.3%
- 0QIU – Novo Nordisk A/S Class B, 2.3%
- ALC – Alcon AG, 2.2%
- 068270 – Celltrion Inc, 2.1%
- 3692 – Hansoh Pharmaceutical Group Co Ltd, 2.1%
- DXCM – DexCom Inc, 1.9%
- 4503 – Astellas Pharma Inc., 1.8%